Pharma Blue: Transforming Danish Healthcare Waste into Circular Design

At Wehlers, our mission is simple: to eliminate waste by redesigning the beginning and the end of a product’s life. While we are well-known for utilizing ocean plastic and e-waste, one of our most pioneering materials tackles a less visible, but equally critical, waste stream: post-consumer pharmaceutical plastic.

This is the story of Pharma Blue, a revolutionary material that gives injection pens a new, permanent life as part of our iconic R.U.M. Chair and closes the loop on plastic from Danish healthcare systems.

The Challenge: Closing the Loop on Medical Plastics

The pharmaceutical industry, essential as it is, generates vast amounts of highly specific plastic waste. Insulin and other injection pens are durable, high-quality plastic objects—but once used, they traditionally enter the general waste stream or are incinerated, wasting valuable, already-processed resources.

We saw this material not as trash, but as a resource waiting to be reused. The challenge was creating a verified, clean, and scalable collection system.

A True Circular Partnership in Denmark

Our solution was a collaboration that brings together consumers, local businesses, and national healthcare partners. The plastics used to create Pharma Blue are meticulously collected via Danish pharmacies. Once users return their pens, we manage the intricate process of cleaning, shredding, and compounding the plastic into our unique, blue composite material, ready for manufacturing.

This local collection model ensures total transparency and minimal transport footprint, making the journey from disposal to design as short and sustainable as possible.

From Injection Pen to the R.U.M. Chair

The resulting material, which we call "R.U.M. Pharma Blue" in its finished form, is structurally strong, aesthetically vibrant, and perfectly suited for durable contract furniture. It represents a quantifiable Co2 saving compared to virgin plastic.

Every single R.U.M. Chair made with the Pharma Blue option contains plastics equivalent to over 140 individual injection pens. This is material that is saved from landfill or incineration and is instead guaranteed a permanent place in the full circular economy through our Take-Back System.

When you choose Pharma Blue, you’re not just selecting a color; you’re selecting a verified impact.

Leading Institutions Join the Circular Movement

The beauty of the Pharma Blue story is that the organizations driving the circular movement are often the same ones using the material in their new furniture.

Major players in Danish healthcare and industry have recognized the value of supporting this closed-loop system:

• Novo Nordisk: As a leading pharmaceutical company in Denmark, their commitment to sustainability is reflected in their choice of furniture, helping to drive demand for the very circular solutions that address industry waste.

• Odense University Hospital (OUH): Hospitals and public institutions often lead the way in responsible procurement. By choosing Pharma Blue seating for their facilities, OUH demonstrates a commitment to sustainable sourcing that literally closes the loop on healthcare waste and reduces their own low-carbon footprint.

These partnerships prove that high-quality, long-lasting design and total environmental responsibility can—and must—go hand-in-hand.

Be Part of the Solution

The Pharma Blue R.U.M. Chair is more than just seating; it’s a visible, physical testament to what is possible when design, technology, and commitment align.

Discover the Pharma Blue option today and learn how your organization can transform waste into a high-quality, fully recyclable asset.